potassium chloride + rice powder + sodium chloride + sodium citrate: clinical use

Prescribing considerations

• Assess whether oral rehydration is appropriate; severe dehydration or inability to retain fluids may require urgent escalation.
• Do not administer to infants under 3 months. Infants aged 3 months to 1 year require medical advice, and children under 2 years with diarrhoea should be assessed promptly.
• Avoid unsupervised use in people following controlled sodium or potassium diets.
• Consider sodium, potassium, aspartame and ethanol content when clinically relevant.
• Persistent or worsening diarrhoea requires reassessment rather than continued self-treatment.

Contraindications and cautions

• Hypersensitivity to an active substance or excipient
• Phenylketonuria because the formulations contain aspartame

Monitoring

• Monitor clinical hydration and response.
• Consider serum electrolytes when electrolyte balance may be disturbed, particularly with severe losses, renal impairment or significant overdose.
• Following substantial overdose, assess and monitor electrolytes until abnormalities resolve.

Clinical pharmacology

The reconstituted low-osmolarity solution supplies sodium, chloride, potassium and citrate. Rice starch supports intestinal solute and water absorption; citrate contributes alkalinising capacity and assists sodium absorption.

Formulation and product differences

• The selected products are raspberry- and blackcurrant-flavoured powders for oral solution.
• Both contain the same active components and share aspartame, hypromellose and ethanol-containing flavour systems; flavouring constituents differ.
• Severe renal or hepatic impairment and intestinal obstruction may make oral treatment inappropriate and require clinical assessment.